Ozempic

Australian tycoon Aron D’Souza wants to organize the controversial Enhanced Games, a competition that still has no date or location, which sets out to test the limits of the human body by allowing performance-enhancing drugs

As more pharmaceutical companies make inroads in the weight loss market, the two firms saw their shares fall more than 10% in the last month

The rich and famous may fill his waiting room, but he is the real star. One of the most famous doctors in New York welcomes EL PAÍS to dismantle the myths and legends of skincare

The scientist — ignored in previous award ceremonies — has won the Princess of Asturias Award for Technical and Scientific Research, for her role in the revolution of medications being used to treat obesity and diabetes

Now we have medications for obesity, but they are not for losing a couple of kilos. An integrative approach of all available measures is needed

Researchers have used artificial intelligence to find out why some people have a better response to GLP-1 agonists

Around the world, 100 companies have debuted weight-loss medications, which have become a multimillion-dollar business. Novo Nordisk’s Ozempic is currently the best-known, but it’s far from the only option

The semaglutide craze is a global phenomenon, but among its unwanted side effects is a premature aging of the face. Health professionals have found themselves administering anti-aging treatments to an ever-younger clientele

The Princeton researcher has published a book in which she reviews what is known about the science of living longer and healthier lives

The businesswoman presented a special on diets and drugs such as Ozempic, which she previously criticized and now, prudently, embraces: ‘Let’s stop shaming other people for being overweight or how they choose to lose or not lose weight’

Half of the people who take these weight loss drugs stop treatment within a year. Most regain two-thirds of their lost weight, but a new study suggests there is a way to avoid the rebound effect

Citi estimates that the fight against obesity will generate revenue of $158 billion in 2035. The main risk for the sector is the difficulty in guaranteeing supply

‘The Hollywood drug’ label doesn’t imply Ozempic is about tricking your brain to lose weight – it’s effective for Type II diabetes and reducing heart attack risk